Abstract：【Objective】To investigate the efficacy and safety of ganglioside combined with levetiracetam in the treatment of secondary epilepsy in children with viral encephalitis. 【Methods】A total of 71 children with secondary epilepsy caused by viral encephalitis admitted to our hospital from January 2021 to January 2023 were selected. According to the treatment method, they were divided into the control group (n=35, conventional treatment + levetiracetam) and the observation group (n=36, combined with ganglioside on the basis of treatment in the control group). The clinical efficacy, serum indicators [neuron specific enolase (NSE), serum interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α)], cerebrospinal fluid indicators [pulmonary surfactant protein D (SP-D), galectin-9 (Gal-9)], as well as the frequency and safety of epileptic seizures after treatment were compared between two groups of children. 【Result】After treatment, the clinical effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). After treatment, the levels of serum NSE, IL-6, TNF-α, and cerebrospinal fluid Gal-9 in both groups were lower than before treatment, and the observation group was lower than the control group (P<0.05); The levels of SP-D in the cerebrospinal fluid of both groups were higher than before treatment, and the observation group was higher than the control group (P<0.05). After discharge, the observation group showed better results than the control group in terms of no seizures or reduced seizure frequency (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). 【Conclusion】The clinical effect of ganglioside combined with levetiracetam in the treatment of secondary epilepsy in children with viral encephalitis is good, improving their immune response, effectively reducing the frequency of seizures, and ensuring good safety.
李传萍, 李华丽. 神经节苷脂联合左乙拉西坦治疗儿童病毒性脑炎继发癫痫的有效性及安全性分析[J]. 医学临床研究, 2024, 41(9): 1392-1394.
LI Chuanping, LI Huali. Efficacy and Safety Analysis of Ganglioside Combined with Levetiracetam in the Treatment of Secondary Epilepsy in Children with Viral Encephalitis. JOURNAL OF CLINICAL RESEARCH, 2024, 41(9): 1392-1394.
2024, Vol. 41 
